Group One Trading’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Group One Trading’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,109	Closed	-$2.27K	–	8369
2026 Q1	$2.27K	Sell	3,109 -9	-0.3%	-$41	﹤0.01%	7014
2025 Q4	$17.4K	Buy	+3,118	New	+$34.7K	﹤0.01%	6458
2024 Q4	–	Sell	-3,779	Closed	-$105K	–	7867
2024 Q3	$109K	Buy	3,779 +2,309	+157%	+$51.3K	﹤0.01%	4103
2024 Q2	$37.6K	Buy	+1,470	New	+$66.8K	﹤0.01%	4742
2023 Q4	–	Sell	-6,465	Closed	-$580K	–	8091
2023 Q3	$631K	Buy	+6,465	New	+$603K	﹤0.01%	2691

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

Group One Trading's RVPH Position: Q2 2026 in Review

Group One Trading sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 3,109 shares — an estimated $2.27K sold.

Group One Trading first reported a position in RVPH in Q3 2023 and held it in 5 quarters. The position peaked at $631K in Q3 2023. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

Group One Trading reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
Group One Trading sold 3,109 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $2.27K.
Group One Trading first reported a position in REVIVA PHARMA HLDGS INC in Q3 2023 and held it in 5 quarters.
Group One Trading's REVIVA PHARMA HLDGS INC position peaked at $631K in Q3 2023.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.